July 26, 2023 Octave Bioscience Closes $30M Extension to Series B Funding, Adds New Strategic Investors Following Strong Growth and Momentum – Businesswire Read More
June 2, 2023 Octave Presents New Data at CMSC Annual Meeting 2023, Adding to Growing Evidence Supporting All Dimensions of its Comprehensive Precision Care Solution for Multiple Sclerosis – Businesswire Read More
March 21, 2023 Analytical validation of a multi-protein, serum-based assay for disease activity assessments in multiple sclerosis – Proteomics Clinical Applications Read More
